{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:56:28Z","timestamp":1787025388260,"version":"build-2736575974"},"reference-count":40,"publisher":"Scientific Scholar","content-domain":{"domain":["nmji.in"],"crossmark-restriction":true},"short-container-title":["NMJI"],"abstract":"<jats:sec id=\"st1\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Injecting drug use (IDU) is associated with several cardiometabolic risks. We aimed to measure the independent effects of IDU behaviour and related factors on serum lipid profile among people who inject drugs (PWIDs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st2\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We did a longitudinal study with six follow-up measurements at an interval of 2 months among 104 PWIDs from 11 selected hotspots under two blocks in West Bengal, India. Generalized estimating equations with robust standard errors analysed the effect of addiction habits on lipid profile parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st3\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean (SD) age of the participants was 27.6 (5.24) years, 36.5% married and 44.3% were unemployed at the time of recruitment. At the baseline, the mean (SD) body mass index (BMI) and fasting blood sugar (FBS) were 20.0 (1.82) kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      and 112.0 (15.90) mg\/dl, respectively. The mean duration of drug use was 2.5 (1.20) years. While 62.5% had normal triglyceride (TG), 14.4% had high total cholesterol (TC) and 69.2% had dyslipidaemia at the baseline. Adjusted for age, BMI, FBS and other addiction-related variables, models showed that longer duration of drug use (&gt;3 years) resulted in higher levels of TG, higher TC-to-high-density lipoprotein ratio and dyslipidaemia. Tobacco use and high FBS level were also risk factors for dyslipidaemia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"st4\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Higher duration of IDU, tobacco use and higher FBS were associated with deranged lipid profile among PWIDs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.25259\/nmji_1_21","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T04:49:44Z","timestamp":1707108584000},"page":"150-156","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Addiction habits in a rural cohort of injection drug users and effects on serum lipid profile: Analysis of a repeated measures study from an eastern state of India"],"prefix":"10.25259","volume":"36","author":[{"given":"ARISTA","family":"LAHIRI","sequence":"first","affiliation":[{"name":"Department of Community Medicine, Dr B.C. Roy Multi-Speciality Medical Research Centre, Indian Institute of Technology, Kharagpur, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SWEETY SUMAN","family":"JHA","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Dr B.C. Roy Multi-Speciality Medical Research Centre, Indian Institute of Technology, Kharagpur, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ARUP","family":"CHAKRABORTY","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Medical College and Hospital, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2024,2,3]]},"reference":[{"key":"10.25259\/NMJI_1_21\/ref-2","doi-asserted-by":"publisher","first-page":"e25287","DOI":"10.1002\/jia2.25287","article-title":"Young people who inject drugs in India have high HIV incidence and behavioural risk: A crosssectional study","volume":"22","author":"Ganapathi","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"10.25259\/NMJI_1_21\/ref-3","article-title":"People who inject drugs","author":"WHO","year":"2018"},{"key":"10.25259\/NMJI_1_21\/ref-4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.drugpo.2016.08.009","article-title":"Injecting drug use in India and the need for policy and program change","volume":"37","author":"Panda","year":"2016","journal-title":"Int J Drug Policy"},{"key":"10.25259\/NMJI_1_21\/ref-5","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/ijcp.12189","article-title":"Illicit drug use and cardiometabolic disease risk: An analysis of 2005-2008 National Health and Nutrition Examination Survey data","volume":"67","author":"Vidot","year":"2013","journal-title":"Int J Clin Pract"},{"key":"10.25259\/NMJI_1_21\/ref-6","doi-asserted-by":"publisher","first-page":"e0147879","DOI":"10.1371\/journal.pone.0147879","article-title":"Burden of liver disease among community-based people who inject drugs (PWID) in Chennai, India","volume":"11","author":"Solomon","year":"2016","journal-title":"PLoS One"},{"key":"10.25259\/NMJI_1_21\/ref-7","first-page":"640","article-title":"Risk of hepatitis C infection among injection drug users in Mizoram, India","volume":"128","author":"Chelleng","year":"2008","journal-title":"Indian J Med Res"},{"key":"10.25259\/NMJI_1_21\/ref-8","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1080\/10826084.2017.1400562","article-title":"Injection partners, HCV, and HIV status among rural persons who inject drugs in Puerto Rico","volume":"53","author":"Habecker","year":"2018","journal-title":"Subst Use Misuse"},{"key":"10.25259\/NMJI_1_21\/ref-9","first-page":"706","article-title":"Epidemiology of hepatitis C virus infection and liver disease among injection drug users (IDUs) in Chennai, India","volume":"132","author":"Mehta","year":"2010","journal-title":"Indian J Med Res"},{"key":"10.25259\/NMJI_1_21\/ref-10","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1186\/s12889-015-2003-z","article-title":"HIV, hepatitis B and C among people who inject drugs: High prevalence of HIV and hepatitis C RNA positive infections observed in Delhi, India","volume":"15","author":"Ray Saraswati","year":"2015","journal-title":"BMC Public Health"},{"key":"10.25259\/NMJI_1_21\/ref-11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1300\/J069v27n02_06","article-title":"Liver disease in injection drug users with hepatitis C, with and without HIV coinfection","volume":"27","author":"Monto","year":"2008","journal-title":"J Addict Dis"},{"key":"10.25259\/NMJI_1_21\/ref-12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1300\/J069v25n02_04","article-title":"Hepatitis and human immunodeficiency virus co-infection among injection drug users in Los Angeles county, California","volume":"25","author":"Fisher","year":"2006","journal-title":"J Addict Dis"},{"key":"10.25259\/NMJI_1_21\/ref-13","doi-asserted-by":"publisher","first-page":"260","DOI":"10.5694\/j.1326-5377.2002.tb04761.x","article-title":"Cocaine use and cardiovascular complications","volume":"177","author":"Vasica","year":"2002","journal-title":"Med J Aust"},{"key":"10.25259\/NMJI_1_21\/ref-14","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/bmj.323.7311.464","article-title":"Cardiovascular complications of recreational drugs","volume":"323","author":"Ghuran","year":"2001","journal-title":"BMJ"},{"key":"10.25259\/NMJI_1_21\/ref-16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0140-6736(11)61138-0","article-title":"Extent of illicit drug use and dependence, and their contribution to the global burden of disease","volume":"379","author":"Degenhardt","year":"2012","journal-title":"Lancet"},{"key":"10.25259\/NMJI_1_21\/ref-17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1471-2458-11-64","article-title":"Spatial distribution and characteristics of injecting drug users (IDU) in five northeastern states of India","volume":"11","author":"Medhi","year":"2011","journal-title":"BMC Public Health"},{"key":"10.25259\/NMJI_1_21\/ref-18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.4103\/0019-5545.196701","article-title":"Injection drug use among children and adolescents in India: Ringing the alarm bells","volume":"58","author":"Dhawan","year":"2016","journal-title":"Indian J Psychiatry"},{"key":"10.25259\/NMJI_1_21\/ref-19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.4103\/ijph.IJPH_279_18","article-title":"Prevalence and predictors of self-reported risk behaviors among male injecting drug users","volume":"63","author":"Sharma","year":"2019","journal-title":"Indian J Public Health"},{"key":"10.25259\/NMJI_1_21\/ref-20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1196\/annals.1369.027","article-title":"Links between nutrition, drug abuse, and the metabolic syndrome","volume":"1074","author":"Virmani","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.25259\/NMJI_1_21\/ref-21","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1080\/10826084.2017.1416404","article-title":"Injection drug use trajectories among migrant populations: A narrative review","volume":"53","author":"Melo","year":"2018","journal-title":"Subst Use Misuse"},{"key":"10.25259\/NMJI_1_21\/ref-22","doi-asserted-by":"publisher","first-page":"h397","DOI":"10.1136\/bmj.h397","article-title":"India's growing problem of injecting drug misuse","volume":"350","author":"Wherley","year":"2015","journal-title":"BMJ"},{"key":"10.25259\/NMJI_1_21\/ref-23","doi-asserted-by":"publisher","first-page":"i10","DOI":"10.18637\/jss.v054.i10","article-title":"GLIMMPSE: Online power computation for linear models with and without a baseline covariate","volume":"54","author":"Kreidler","year":"2013","journal-title":"J Stat Softw"},{"key":"10.25259\/NMJI_1_21\/ref-24","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/1471-2288-13-100","article-title":"Selecting a sample size for studies with repeated measures","volume":"13","author":"Guo","year":"2013","journal-title":"BMC Med Res Methodol"},{"key":"10.25259\/NMJI_1_21\/ref-25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"WHO Expert Consultation","year":"2004","journal-title":"Lancet"},{"key":"10.25259\/NMJI_1_21\/ref-27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4103\/heartindia.heartindia_2_19","article-title":"Coronary risk prediction by the correlation of total cholesterol\/high-density lipoprotein, triglyceride\/high-density lipoprotein, low-density lipoprotein\/high-density lipoprotein ratios, non-high-density lipoprotein, apolipoprotein-B, and high-sensitivity C-reactive protein with low-density lipoprotein in Indian patients under statin therapy","volume":"7","author":"Badrinath","year":"2019","journal-title":"Heart India"},{"key":"10.25259\/NMJI_1_21\/ref-28","doi-asserted-by":"publisher","first-page":"e563","DOI":"10.1161\/CIR.0000000000000724","article-title":"2019 ACC\/AHA Guideline on the primary prevention of cardiovascular disease: Executive summary: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.25259\/NMJI_1_21\/ref-29","doi-asserted-by":"publisher","first-page":"S178","DOI":"10.1016\/j.jcjd.2017.10.019","article-title":"Dyslipidemia","volume":"42","author":"Mancini","year":"2018","journal-title":"Can J Diabetes"},{"key":"10.25259\/NMJI_1_21\/ref-30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2307\/2531248","article-title":"Longitudinal data analysis for discrete and continuous outcomes","volume":"42","author":"Zeger","year":"1986","journal-title":"Biometrics"},{"key":"10.25259\/NMJI_1_21\/ref-31","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/sim.4780111406","article-title":"An overview of methods for the analysis of longitudinal data","volume":"11","author":"Zeger","year":"1992","journal-title":"Stat Med"},{"key":"10.25259\/NMJI_1_21\/ref-32","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1067\/mhj.2002.125009","article-title":"Coronary artery calcification, atherogenic lipid changes, and increased erythrocyte volume in black injection drug users infected with human immunodeficiency virus-1 treated with protease inhibitors","volume":"144","author":"Meng","year":"2002","journal-title":"Am Heart J"},{"key":"10.25259\/NMJI_1_21\/ref-33","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00038-015-0698-3","article-title":"Cardiovascular disease among people with drug use disorders","volume":"60","author":"Thylstrup","year":"2015","journal-title":"Int J Public Health"},{"key":"10.25259\/NMJI_1_21\/ref-34","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/00042560-199602010-00011","article-title":"Changes in membrane enzymes and glycosphingolipids in lymphocytes from HIV-1-infected and noninfected intravenous drug users","volume":"11","author":"Leoni","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.25259\/NMJI_1_21\/ref-35","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/10826084.2019.1669660","article-title":"Initiating persons into injection drug use in rural West Virginia, USA","volume":"55","author":"White","year":"2020","journal-title":"Subst Use Misuse"},{"key":"10.25259\/NMJI_1_21\/ref-36","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1161\/01.CIR.102.19.2347","article-title":"Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II","volume":"102","author":"De Oliveira e Silva Elizabeth","year":"2000","journal-title":"Circulation"},{"key":"10.25259\/NMJI_1_21\/ref-37","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3945\/ajcn.116.144832","article-title":"Longitudinal study of alcohol consumption and HDL concentrations: A community-based study","volume":"105","author":"Huang","year":"2017","journal-title":"Am J Clin Nutr"},{"key":"10.25259\/NMJI_1_21\/ref-38","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3390\/nu10091237","article-title":"Moderate beer intake and cardiovascular health in overweight individuals","volume":"10","author":"Padro","year":"2018","journal-title":"Nutrients"},{"key":"10.25259\/NMJI_1_21\/ref-39","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1476-511X-11-94","article-title":"Cigarette smoking and its association with serum lipid\/lipoprotein among Chinese nonagenarians\/centenarians","volume":"11","author":"Yan-Ling","year":"2012","journal-title":"Lipids Health Dis"},{"key":"10.25259\/NMJI_1_21\/ref-40","doi-asserted-by":"publisher","first-page":"482","DOI":"10.2337\/diacare.29.02.06.dc05-2225","article-title":"Association between cigarette smoking and metabolic syndrome: Response to Oh et al","volume":"29","author":"Masulli","year":"2006","journal-title":"Diabetes Care"},{"key":"10.25259\/NMJI_1_21\/ref-41","doi-asserted-by":"publisher","first-page":"e000358","DOI":"10.1136\/openhrt-2015-000358","article-title":"Cardiovascular disease risk factors in relation to smoking behaviour and history: A population-based cohort study","volume":"3","author":"Keto","year":"2016","journal-title":"Open Heart"},{"key":"10.25259\/NMJI_1_21\/ref-42","doi-asserted-by":"publisher","first-page":"630","DOI":"10.4103\/0250-474X.169033","article-title":"Association of fasting plasma glucose and serum lipids in Type 2 diabetics","volume":"77","author":"Khadke","year":"2015","journal-title":"Indian J Pharm Sci"},{"key":"10.25259\/NMJI_1_21\/ref-43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1300\/J069v14n02_01","article-title":"Reliability of interview responses of injecting drug users","volume":"14","author":"Ross","year":"1995","journal-title":"J Addict Dis"}],"container-title":["The National Medical Journal of India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/nmji.in\/addiction-habits-in-a-rural-cohort-of-injection-drug-users-and-effects-on-serum-lipid-profile-analysis-of-a-repeated-measures-study-from-an-eastern-state-of-india\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nmji.in\/addiction-habits-in-a-rural-cohort-of-injection-drug-users-and-effects-on-serum-lipid-profile-analysis-of-a-repeated-measures-study-from-an-eastern-state-of-india\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T04:49:58Z","timestamp":1707108598000},"score":1,"resource":{"primary":{"URL":"https:\/\/nmji.in\/addiction-habits-in-a-rural-cohort-of-injection-drug-users-and-effects-on-serum-lipid-profile-analysis-of-a-repeated-measures-study-from-an-eastern-state-of-india\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,3]]},"references-count":40,"alternative-id":["10.25259\/NMJI_1_21"],"URL":"https:\/\/doi.org\/10.25259\/nmji_1_21","relation":{},"ISSN":["2583-150X","0970-258X"],"issn-type":[{"value":"2583-150X","type":"electronic"},{"value":"0970-258X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,3]]},"article-number":"150"}}